|
CA2921162A1
(en)
|
2013-05-01 |
2014-11-06 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
US10280423B2
(en)
*
|
2014-05-01 |
2019-05-07 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating complement factor B expression
|
|
US10570169B2
(en)
|
2014-05-22 |
2020-02-25 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
EP3151839A4
(en)
*
|
2014-06-06 |
2018-02-28 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for enhanced intestinal absorption of conjugated oligomeric compounds
|
|
ES2747842T3
(es)
|
2014-12-15 |
2020-03-11 |
Dicerna Pharmaceuticals Inc |
Acidos nucleicos de doble hebra modificados por ligando
|
|
US11298427B2
(en)
|
2015-05-29 |
2022-04-12 |
Ascendis Pharma A/S |
Prodrugs comprising a pyroglutamate linker
|
|
WO2017010575A1
(ja)
*
|
2015-07-16 |
2017-01-19 |
協和発酵キリン株式会社 |
β２ＧＰＩ遺伝子発現抑制核酸複合体
|
|
CN105524124B
(zh)
*
|
2015-12-31 |
2018-10-30 |
天津英吉诺科技有限公司 |
一种n-乙酰氨基半乳糖的绿色合成方法
|
|
JP6853193B2
(ja)
|
2016-01-29 |
2021-03-31 |
協和キリン株式会社 |
核酸複合体
|
|
US10246709B2
(en)
|
2016-03-07 |
2019-04-02 |
Arrowhead Pharmaceuticals, Inc. |
Targeting ligands for therapeutic compounds
|
|
EP3442983A1
(en)
*
|
2016-04-14 |
2019-02-20 |
H. Hoffnabb-La Roche Ag |
TRITYL-MONO-Ga1NAc COMPOUNDS AND THEIR USE
|
|
WO2017188898A1
(en)
|
2016-04-29 |
2017-11-02 |
Nanyang Technological University |
G-quadruplex-containing antisense oligonucleotides
|
|
EP3498724B1
(en)
|
2016-06-30 |
2023-06-21 |
Kyowa Kirin Co., Ltd. |
Nucleic acid complex
|
|
AU2017296195A1
(en)
|
2016-07-11 |
2019-01-24 |
Translate Bio Ma, Inc. |
Nucleic acid conjugates and uses thereof
|
|
EP3484908A4
(en)
|
2016-07-15 |
2020-04-08 |
AM Chemicals Llc |
NON-NUCLEOSIDIC SOLID CARRIERS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTID SYNTHESIS
|
|
JP6989521B2
(ja)
|
2016-09-02 |
2022-01-05 |
アローヘッド ファーマシューティカルズ インコーポレイテッド |
標的化リガンド
|
|
KR20190065341A
(ko)
|
2016-10-06 |
2019-06-11 |
아이오니스 파마수티컬즈, 인코포레이티드 |
올리고머 화합물들의 접합 방법
|
|
CN110536964A
(zh)
|
2017-03-10 |
2019-12-03 |
国立研究开发法人国立成育医疗研究中心 |
反义寡核苷酸和糖原贮积病Ia型预防或治疗用组合物
|
|
CN110636865A
(zh)
*
|
2017-03-22 |
2019-12-31 |
加利福尼亚大学董事会 |
修饰的寡核苷酸及其治疗用途
|
|
RS63836B1
(sr)
|
2017-04-05 |
2023-01-31 |
Silence Therapeutics Gmbh |
Proizvodi i sastavi
|
|
US20210108207A1
(en)
|
2017-04-28 |
2021-04-15 |
Kyowa Kirin Co., Ltd. |
Oligonucleotide derivative or salt thereof
|
|
WO2019027009A1
(ja)
*
|
2017-08-02 |
2019-02-07 |
協和発酵キリン株式会社 |
核酸複合体
|
|
TW201909925A
(zh)
*
|
2017-08-02 |
2019-03-16 |
日商協和醱酵麒麟有限公司 |
核酸複合體
|
|
SG11202002149XA
(en)
*
|
2017-09-14 |
2020-04-29 |
Janssen Biopharma Inc |
Galnac derivatives
|
|
WO2019105435A1
(zh)
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
CN118236391A
(zh)
|
2017-12-01 |
2024-06-25 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
US11660347B2
(en)
|
2017-12-01 |
2023-05-30 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, composition and conjugate containing same, preparation method, and use thereof
|
|
JP7261494B2
(ja)
|
2017-12-01 |
2023-04-20 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、当該核酸を含む組成物及び複合体ならびに調製方法と使用
|
|
CN110945131B
(zh)
*
|
2017-12-01 |
2024-05-28 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
CN110997919B
(zh)
|
2017-12-01 |
2024-04-02 |
苏州瑞博生物技术股份有限公司 |
双链寡核苷酸、含双链寡核苷酸的组合物与缀合物及制备方法和用途
|
|
CN111050807B
(zh)
*
|
2017-12-01 |
2024-05-28 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
CN110959011B
(zh)
|
2017-12-29 |
2023-03-28 |
苏州瑞博生物技术股份有限公司 |
缀合物及其制备方法和用途
|
|
US12178855B2
(en)
|
2018-01-10 |
2024-12-31 |
Translate Bio Ma, Inc. |
Compositions and methods for facilitating delivery of synthetic nucleic acids to cells
|
|
EP3763815A4
(en)
|
2018-03-09 |
2021-12-15 |
Daiichi Sankyo Company, Limited |
THERAPEUTIC FOR GLYCOGEN STORAGE DISEASE OF TYPE IA
|
|
US20210155926A1
(en)
*
|
2018-04-05 |
2021-05-27 |
Silence Therapeutics Gmbh |
siRNAs WITH AT LEAST TWO LIGANDS AT DIFFERENT ENDS
|
|
EP3790970A1
(en)
|
2018-05-07 |
2021-03-17 |
Alnylam Pharmaceuticals Inc. |
Extrahepatic delivery
|
|
EP3842534A4
(en)
*
|
2018-08-21 |
2022-07-06 |
Suzhou Ribo Life Science Co., Ltd. |
NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND CONJUGATE WITH NUCLEIC ACID AND THEIR USE
|
|
EP3862024A4
(en)
*
|
2018-09-30 |
2022-08-17 |
Suzhou Ribo Life Science Co., Ltd. |
SIRNA CONJUGATE, METHOD FOR ITS PRODUCTION AND ITS USE
|
|
GB2579253A
(en)
*
|
2018-11-28 |
2020-06-17 |
Pedanius Therapeutics Ltd |
Antibacterial antisense agents
|
|
EP3888663A1
(en)
|
2018-11-30 |
2021-10-06 |
Kyowa Kirin Co., Ltd. |
Nucleic acid complex
|
|
CN112423794A
(zh)
|
2018-12-28 |
2021-02-26 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
GB201821269D0
(en)
|
2018-12-28 |
2019-02-13 |
Nippon Shinyaku Co Ltd |
Myostatin signal inhibitor
|
|
CN111377985B
(zh)
*
|
2018-12-29 |
2023-11-10 |
苏州瑞博生物技术股份有限公司 |
化合物和缀合物及其制备方法和用途
|
|
CN111377984B
(zh)
*
|
2018-12-29 |
2024-03-05 |
苏州瑞博生物技术股份有限公司 |
化合物和缀合物及其制备方法和用途
|
|
WO2020147847A1
(zh)
*
|
2019-01-18 |
2020-07-23 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
CN113811613B
(zh)
*
|
2019-05-22 |
2024-04-05 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
AU2020280439B2
(en)
*
|
2019-05-22 |
2025-08-14 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
|
|
TWI863999B
(zh)
|
2019-05-22 |
2024-12-01 |
大陸商蘇州瑞博生物技術股份有限公司 |
ｓｉＲＮＡ綴合物、其用途及使用其之方法
|
|
JP7663951B2
(ja)
|
2019-05-22 |
2025-04-17 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、薬物組成物及び複合体ならびに調製方法と使用
|
|
CN111973618B
(zh)
*
|
2019-05-23 |
2024-02-02 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与siRNA缀合物及制备方法和用途
|
|
CN111973619B
(zh)
*
|
2019-05-23 |
2024-01-30 |
苏州瑞博生物技术股份有限公司 |
核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途
|
|
US20220315929A1
(en)
|
2019-05-24 |
2022-10-06 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition and conjugate, preparation method therefor and use thereof
|
|
WO2020238766A1
(zh)
|
2019-05-24 |
2020-12-03 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
CN118217305A
(zh)
*
|
2019-05-24 |
2024-06-21 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
CN112007040B
(zh)
*
|
2019-05-31 |
2024-01-30 |
苏州瑞博生物技术股份有限公司 |
用于治疗乙型病毒性肝炎的联合用药物
|
|
EP4023659A4
(en)
|
2019-08-29 |
2024-02-28 |
Suzhou Ribo Life Science Co., Ltd. |
COMPOUND AND DRUG CONJUGATE, PRODUCTION METHOD AND USE THEREOF
|
|
WO2021049504A1
(ja)
|
2019-09-10 |
2021-03-18 |
第一三共株式会社 |
肝臓送達用ＧａｌＮＡｃ－オリゴヌクレオチドコンジュゲートおよび製造方法
|
|
CN115003330A
(zh)
|
2019-09-23 |
2022-09-02 |
科纳克斯资本 |
作为疫苗和诊断工具的新糖缀合物
|
|
AU2020378414A1
(en)
*
|
2019-11-06 |
2022-05-26 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|
|
IL293341B1
(en)
*
|
2019-11-26 |
2026-04-01 |
Dtx Pharma Inc |
A compound comprising a nucleic acid and a half-life extension motif
|
|
CN112876534B
(zh)
*
|
2019-11-29 |
2024-02-09 |
苏州瑞博生物技术股份有限公司 |
肝靶向化合物及缀合物
|
|
KR20220133878A
(ko)
*
|
2020-01-29 |
2022-10-05 |
스미또모 가가꾸 가부시끼가이샤 |
핵산 올리고머의 제조 방법
|
|
CN111269279B
(zh)
*
|
2020-02-24 |
2022-08-05 |
陕西师范大学 |
一种在温和条件下制备卤代糖的方法
|
|
WO2021195218A1
(en)
|
2020-03-24 |
2021-09-30 |
Generation Bio Co. |
Non-viral dna vectors and uses thereof for expressing gaucher therapeutics
|
|
AU2021244555A1
(en)
|
2020-03-24 |
2022-11-24 |
Generation Bio Co. |
Non-viral dna vectors and uses thereof for expressing factor ix therapeutics
|
|
CN113683651A
(zh)
*
|
2020-05-19 |
2021-11-23 |
上海京新生物医药有限公司 |
一种GalNAc中间体的制备方法
|
|
JP2023526533A
(ja)
|
2020-05-22 |
2023-06-21 |
ウェイブ ライフ サイエンシズ リミテッド |
二本鎖オリゴヌクレオチド組成物及びそれに関連する方法
|
|
TWI879977B
(zh)
|
2020-06-10 |
2025-04-11 |
大陸商正大天晴藥業集團股份有限公司 |
雙鏈siRNA類似物的共軛物
|
|
BR112023012377A2
(pt)
|
2020-12-23 |
2023-10-24 |
Flagship Pioneering Innovations Vi Llc |
Composições de trems modificadas e usos das mesmas
|
|
US20250320500A1
(en)
|
2020-12-29 |
2025-10-16 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition and sirna conjugate containing the nucleic acid, preparation method therefor, and use thereof
|
|
WO2022189861A1
(en)
|
2021-03-08 |
2022-09-15 |
Tollys |
Carbohydrate conjugates of tlr3 ligands and uses thereof
|
|
WO2022232289A1
(en)
|
2021-04-27 |
2022-11-03 |
Generation Bio Co. |
Non-viral dna vectors expressing therapeutic antibodies and uses thereof
|
|
EP4329884A1
(en)
|
2021-04-27 |
2024-03-06 |
Generation Bio Co. |
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof
|
|
WO2022246195A1
(en)
*
|
2021-05-20 |
2022-11-24 |
Olix Us, Inc. |
Functional moieties and their uses and synthetic preparation
|
|
CN115572241B
(zh)
*
|
2021-06-21 |
2024-08-30 |
润佳（苏州）医药科技有限公司 |
双价化合物、偶联物及其用途
|
|
JPWO2023282346A1
(OSRAM)
|
2021-07-08 |
2023-01-12 |
|
|
|
TW202308664A
(zh)
|
2021-07-08 |
2023-03-01 |
日商日本新藥股份有限公司 |
腎毒性減輕劑
|
|
EP4368186A4
(en)
|
2021-07-08 |
2025-06-25 |
Nippon Shinyaku Co., Ltd. |
NEPHROTOXICITY REDUCING AGENT
|
|
JP2024528634A
(ja)
|
2021-07-16 |
2024-07-30 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
二本鎖オリゴヌクレオチド、二本鎖オリゴヌクレオチドを含む組成物及び複合体並びに調製方法と使用
|
|
WO2023284559A1
(zh)
|
2021-07-16 |
2023-01-19 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
EP4380576A4
(en)
*
|
2021-08-03 |
2026-04-29 |
Verve Therapeutics Inc |
RNA TARGETED COMPOSITIONS AND ADMINISTRATION METHODS
|
|
US12465647B2
(en)
|
2021-08-05 |
2025-11-11 |
Sanegene Bio Usa Inc. |
1′-alkyl modified ribose derivatives and methods of use
|
|
AU2022352676A1
(en)
|
2021-09-22 |
2024-03-14 |
Sanegene Bio Usa Inc. |
2'-alkyl or 3'- alkyl modified ribose derivatives for use in the in-vivo delivery of oligonucleotides
|
|
JP2024542929A
(ja)
|
2021-10-05 |
2024-11-19 |
セーンジーン バイオ ユーエスエー インコーポレイティド |
ポリヒドロキシル化されたシクロペンタン誘導体及び使用方法
|
|
WO2023097251A1
(en)
*
|
2021-11-23 |
2023-06-01 |
Yale University |
Oligonucleotide-containing transcription factor targeting chimeras
|
|
JP2025508785A
(ja)
|
2022-02-22 |
2025-04-10 |
セーンジーン バイオ ユーエスエー インコーポレイティド |
５’修飾炭素環式リボヌクレオチド誘導体及び使用方法
|
|
CN120129745A
(zh)
|
2022-03-10 |
2025-06-10 |
日本新药株式会社 |
抗病毒反义低聚物
|
|
AU2023235112A1
(en)
|
2022-03-14 |
2024-10-17 |
Generation Bio Co. |
Heterologous prime boost vaccine compositions and methods of use
|
|
JPWO2023176863A1
(OSRAM)
|
2022-03-16 |
2023-09-21 |
|
|
|
US20250188478A1
(en)
|
2022-03-16 |
2025-06-12 |
Daiichi Sankyo Company, Limited |
siRNA SUPPRESSING EXPRESSION OF TRANSFERRIN RECEPTOR 2
|
|
WO2023207615A1
(zh)
*
|
2022-04-26 |
2023-11-02 |
南京明德新药研发有限公司 |
一类含由天然核苷酸组成突出端的双链RNAi化合物
|
|
US20250346620A1
(en)
*
|
2022-04-28 |
2025-11-13 |
Dicerna Pharmaceuticals, Inc. |
Methods for synthesis of peracetylgalactosamine-1-pentanoic acid
|
|
JP2025516680A
(ja)
|
2022-05-13 |
2025-05-30 |
アルナイラム ファーマシューティカルズ， インコーポレイテッド |
一本鎖ループオリゴヌクレオチド
|
|
WO2023250112A1
(en)
|
2022-06-22 |
2023-12-28 |
Flagship Pioneering Innovations Vi, Llc |
Compositions of modified trems and uses thereof
|
|
CN119654412A
(zh)
*
|
2022-06-27 |
2025-03-18 |
中美瑞康核酸技术(南通)研究院有限公司 |
激活补体因子h表达的寡核苷酸调节剂
|
|
EP4547683A2
(en)
|
2022-06-30 |
2025-05-07 |
Alnylam Pharmaceuticals, Inc. |
Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
|
|
WO2024015796A1
(en)
|
2022-07-11 |
2024-01-18 |
Sanegene Bio Usa Inc. |
Optimized 2'- modified ribose derivatives and methods of use
|
|
AU2023320578A1
(en)
|
2022-08-05 |
2025-02-13 |
Sanegene Bio Usa Inc. |
Double stranded rna targeting angiotensinogen (agt) and methods of use thereof
|
|
US20260055426A1
(en)
|
2022-08-19 |
2026-02-26 |
Generation Bio Co. |
CLEAVABLE CLOSED-ENDED DNA (ceDNA) AND METHODS OF USE THEREOF
|
|
IL320218A
(en)
|
2022-10-14 |
2025-06-01 |
Sanegene Bio Usa Inc |
Small interfering RNA targeting C3 and its uses
|
|
KR20250116697A
(ko)
|
2022-12-02 |
2025-08-01 |
상하이 아르고 바이오파마슈티칼 씨오., 엘티디. |
비시클릭 무염기 핵산 유사체 및 이들로부터 제조된 올리고머 화합물
|
|
CN120569477A
(zh)
|
2022-12-19 |
2025-08-29 |
美国圣因生物股份有限公司 |
靶向cfb的小干扰rna及其用途
|
|
CN116178458A
(zh)
*
|
2022-12-26 |
2023-05-30 |
成都药明康德新药开发有限公司 |
一种糖苷化合物的合成
|
|
WO2024160204A1
(en)
*
|
2023-01-30 |
2024-08-08 |
Primelink Biotherapeutics (Suzhou) Co., Ltd. |
Polymer-oligonucleotide conjugates
|
|
US20240309383A1
(en)
|
2023-02-24 |
2024-09-19 |
Suzhou Sanegene Bio Inc. |
Small interfering rna targeting hbv and uses thereof
|
|
WO2024186673A2
(en)
|
2023-03-03 |
2024-09-12 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting apoc3 and uses thereof
|
|
WO2024188174A1
(zh)
|
2023-03-10 |
2024-09-19 |
苏州瑞博生物技术股份有限公司 |
一种药物组合物及其用途
|
|
CN121729491A
(zh)
|
2023-05-12 |
2026-03-24 |
阿尔尼拉姆制药公司 |
单链环寡核苷酸
|
|
EP4706646A1
(en)
|
2023-06-01 |
2026-03-11 |
Sunshine Lake Pharma Co., Ltd. |
Novel double-stranded sirna, conjugate thereof, and use thereof
|
|
CN116854771A
(zh)
*
|
2023-06-14 |
2023-10-10 |
北京炫景瑞医药科技有限公司 |
GalNAc衍生物、缀合物、组合物以及它们的用途
|
|
EP4731764A2
(en)
|
2023-06-21 |
2026-04-29 |
Sanegene Bio USA Inc. |
Double stranded rna targeting proprotein convertase subtilisin kexin 9 (pcsk9) and methods of use thereof
|
|
CN119219716A
(zh)
*
|
2023-06-30 |
2024-12-31 |
上海维申医药有限公司 |
新型GalNAc的靶向递送片段及其制备和应用
|
|
WO2025016441A1
(zh)
*
|
2023-07-19 |
2025-01-23 |
上海维申医药有限公司 |
新型GalNAc的靶向递送片段及其制备和应用
|
|
US20250064939A1
(en)
|
2023-07-24 |
2025-02-27 |
Sanegene Bio Usa Inc. |
Lipid-based enhancement agent for rna delivery and therapy
|
|
AU2024321710A1
(en)
|
2023-08-04 |
2026-03-05 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Double-stranded ribonucleic acid targeting pd-l1
|
|
AU2024321098A1
(en)
|
2023-08-09 |
2026-03-19 |
Beijing Foyou Pharma Co., Ltd |
Sirna for inhibiting dgat2 gene expression, sirna conjugate or prodrug and pharmaceutical composition thereof, and use thereof
|
|
WO2025042786A1
(en)
|
2023-08-18 |
2025-02-27 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
TW202511489A
(zh)
|
2023-08-31 |
2025-03-16 |
大陸商正大天晴藥業集團股份有限公司 |
靶向凝血因子ｘｉ的雙鏈核糖核酸
|
|
CN117384226B
(zh)
*
|
2023-09-14 |
2025-12-26 |
苏州盛诺维生物科技有限公司 |
一种GalNAc类化合物的合成工艺
|
|
WO2025096809A1
(en)
|
2023-10-31 |
2025-05-08 |
Korro Bio, Inc. |
Oligonucleotides comprising phosphoramidate internucleotide linkages
|
|
TW202523695A
(zh)
|
2023-11-22 |
2025-06-16 |
美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 |
用於治療非酒精性脂肪性肝病之方法及組成物
|
|
WO2025140299A1
(zh)
*
|
2023-12-26 |
2025-07-03 |
广东东阳光药业股份有限公司 |
一种新型的化合物及其用途
|
|
WO2025155911A1
(en)
|
2024-01-18 |
2025-07-24 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of hurler syndrome
|
|
WO2025207934A1
(en)
|
2024-03-28 |
2025-10-02 |
Lycia Therapeutics, Inc. |
Lysosomal targeting bifunctional molecules for degradation of thyroid stimulating hormone receptor autoantibodies
|
|
WO2025228441A2
(en)
|
2024-04-30 |
2025-11-06 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting inhbe and uses thereof
|
|
CN118146284B
(zh)
*
|
2024-05-08 |
2024-07-26 |
北京悦康科创医药科技股份有限公司 |
一种GalNAc化合物、其与寡核苷酸缀合物及制备方法
|
|
WO2025245188A2
(en)
|
2024-05-21 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Methods of treating liver steatosis and non-alcoholic fatty liver disease
|
|
WO2026017140A2
(en)
|
2024-07-18 |
2026-01-22 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting fxi and uses thereof
|
|
WO2026041067A2
(en)
|
2024-08-20 |
2026-02-26 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting myostatin (mstn) and uses thereof
|
|
WO2026046411A1
(en)
|
2024-09-02 |
2026-03-05 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting plasminogen (plg) and uses thereof
|
|
WO2026085495A1
(en)
|
2024-10-18 |
2026-04-23 |
Generation Bio Co. |
Synthetic partially single-stranded nucleic acid compositions and uses and methods therefor
|
|
CN121081660A
(zh)
*
|
2025-02-21 |
2025-12-09 |
上海辉棵生物医药有限公司 |
一种靶向递送系统及其核酸缀合物的制备方法与用途
|